University of Alabama at Birmingham
Dr. Camilla (Margaroli) Bell received her master degree in Medical Biology at the University of Lausanne (Switzerland) in 2015, and her PhD in Immunology and Molecular Pathogenesis in 2019 from the Graduate Division of Biological and Biomedical Sciences at Emory University (Atlanta, GA). During her thesis in Dr. Tirouvanziam’s group, Dr. Bell studied the mechanisms leading to neutrophil plasticity in chronic diseases, with a primary focus on lung inflammation in infants and adults affected by cystic fibrosis. She continued working on mechanisms regulating airway inflammation upon infection (including SARS-CoV-2) during her postdoctoral training in Dr. Amit Gaggar’s group at the University of Alabama at Birmingham (UAB).
Currently, Dr. Bell is an assistant professor in the Department of Pathology at UAB where she continues to pursue translational research focused on modulation of inflammatory responses in cystic fibrosis.
S07.2- Nightwatch at the Mucosal Wall: A Tale of Host-Pathogen Dynamics
Thursday, October 23, 2025
2:30 PM - 4:30 PM PDT
W17.3- Antigen-experienced CD4+ T cell clonal expansion characterizes CF-related diabetes
Friday, October 24, 2025
7:45 AM - 9:45 AM PDT
W22--Reprogramming Immune Dysfunction in CF
Friday, October 24, 2025
10:15 AM - 12:15 PM PDT